Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-01-24

FDA Approved: HYDROXYZINE PAMOATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva’s supplemental application for hydroxyzine pamoate, confirming its status as an approved generic drug. The action relates to a supplementa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxyzine pamoate (Hydroxyzine pamoate)

Snippet

SUPPL AP for HYDROXYZINE PAMOATE (HYDROXYZINE PAMOATE)